Company Filing History:
Years Active: 2004
Title: Gunther Hollopeter - Innovator in P2Y12 Receptor Research
Introduction
Gunther Hollopeter is a renowned inventor based in San Francisco, CA. With a keen focus on pharmaceutical innovations, he has made significant contributions to the field of receptor research. His expertise is evident in his patented work aimed at understanding and modulating key biological processes.
Latest Patents
Gunther holds a patent for "Methods of identifying agents that modulate P2Y12 receptor activity." This groundbreaking invention introduces a novel subtype of the P2Y purinergic receptor, which plays a critical role in platelet and brain function by coupling with a pertussis toxin-sensitive G protein (Gi). The patent also encompasses nucleic acids encoding the receptor and associated screening and therapeutic methods, which could pave the way for new treatments in pharmacology.
Career Highlights
Gunther is currently employed at Portola Pharmaceuticals, Inc., where he engages in cutting-edge research aimed at developing new therapeutic strategies. His tenure at this leading company exemplifies his commitment to advancing scientific understanding and innovation within the pharmaceutical landscape.
Collaborations
Throughout his career, Gunther has collaborated with esteemed colleagues such as Pamela B. Conley and Hans-Michael Jantzen. These partnerships highlight his ability to work effectively within a team to push the boundaries of life sciences and pharmaceutical discovery.
Conclusion
Gunther Hollopeter's contributions to the field of receptor research underscore the importance of innovation in developing new therapeutic options. His work not only reflects his personal dedication but also showcases the collaborative efforts that are vital for advancements in medicine. As he continues his journey in the scientific community, his inventions promise to make a significant impact on healthcare.